“The simple, yet elegant and informative data presentation format allows quick assessment of the patient.”

– Dr. Gene Trobaugh, Cardiologist (Enumclaw, WA)

BardyDx, Inc was founded to address the long-standing complaint in cardiac arrhythmia monitoring that traditional monitors were large, bulky, uncomfortable, and typically record noisy QRS signals. Our goal: to completely redesign an arrhythmia monitor with optimal signal detection, comfort, and ease of use.

JON HUNT, Ph.D.

President and Chief Executive Officer

Jon has 28 years’ experience in the Medical/Medical Device Industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He leads effectively in both small entrepreneurial corporate environments and in Fortune 500 medical device corporations.

 

Jon joined Bardy Diagnostics, Inc. on October 1, 2013 after spending the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation in June, 2012). He spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. He began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs; he subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, he held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing. Jon has extensive experience providing key support to cardiac electrophysiologists around the world to ensure that they, and their patients, implement new technologies safely and effectively.

GUST H. BARDY, M.D.

Chief Medical Officer

Gust H. Bardy, M.D. is a cardiac electrophysiologist with research interests in cardiac defibrillator technology, cardiac arrest, and atrial fibrillation as they affect the public health. He has been a researcher in the field of sudden death and disabling cardiac rhythm disorders for 35 years. Dr.Bardy has also developed technological solutions to patient rhythm problems with hundreds of patents issued globally, most of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. His primary goals are to help the patient first, the physician second, and other interests third.

 

Bardy Diagnostics was founded by Dr. Bardy April 26, 2013 on the principal that non-invasive ECG monitoring should provide an excellent quality atrial signal, or P-wave. (The QRS is easy.) His personal frustration with poor P-wave quality on his own patient’s non-invasive ECG monitors provided the impetus to improve the quality of ECG signals upon which physicians depend for an appropriate diagnosis.